📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
30
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ASTH.
💹 Market Data
Market Cap$1.90B
Shares Outstanding49.58M
Float37.60M
Cash$478.38M
Debt$1.07B
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 2.5% shares (2025Q4 vs prior)
178 institutional holders · 29.43M shares
#1
BlackRock, Inc.
6.16M shares
#2
VANGUARD GROUP INC
4.24M shares
#3
325 CAPITAL LLC
1.84M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest2.86M
Days to Cover5.6
% of Float7.6%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2024
xbrl
XBRL CONVERTIBLE
Dec 31, 2017
4
INSIDER TRANSACTION
Apr 08, 2026
4
INSIDER TRANSACTION
Apr 08, 2026
4
INSIDER TRANSACTION
Apr 08, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for ASTH
📊 ASTH FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ASTH Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.